
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]

NCCS Comments on the FDA’s PDUFA Proposed Commitment Letter
NCCS submitted comments to the Food and Drug Administration (FDA) on the letter representing the agreement between FDA and regulated industry on goals for the re-authorization of the Prescription Drug User Fee Act (PDUFA VI). NCCS participated in the PDUFA stakeholder meetings held over the last year, and we support the role [...]

NCCS Comments on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Proposed Rule
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed rule on the Medicare Access and CHIP…

NCCS Joins Letter to Reagan-Udall Foundation Regarding the Expanded Access Navigator Program
NCCS joined with patient advocacy organizations in the Cancer Leadership Council (CLC) in submitting comments to the Reagan-Udall Foundation…

A Voice for Cancer Survivors in the PDUFA Stakeholder Meetings
In 1992, Congress passed the first Prescription Drug User Fee Act (PDUFA), a law that allows the Food and Drug Administration (FDA)…

NCCS Joins Patient Advocates in Proposing Alternative Approach to CMS’ Part B Drug Payment Demonstration
NCCS joined with patient advocacy organizations in the Cancer Leadership Council (CLC) in submitting comments to the Centers for Medicare…

CMS’ Hospital Compare Star Ratings a Valuable Tool for Cancer Survivors to Make Informed Decisions About Their Care
The Centers for Medicare and Medicaid Services (CMS) announced that they are postponing the release of their Hospital Compare Star…

NCCS Submits Comments to the Senate Finance Committee’s Bipartisan Chronic Care Working Group
NCCS recently submitted comments on the Senate Finance Committee's "Bipartisan Chronic Care Working Group Policy Options Document"…

NCCS Offers Comments on Alternative Payment Models for Cancer Care as Part of the Merit-Based Incentive Payment System (MIPS)
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to its request for feedback on the implementation…

NCCS Submits Letters, Joins Cancer Leadership Council and C-P Alliance, in Comments to CMS on Proposed Revisions to Medicare Physician Fee Schedule
NCCS submitted letters to the Centers for Medicare and Medicaid Services (CMS) on its proposed revisions to the Medicare physician…

NCCS Responds to Draft ASCO Conceptual Framework to Assess the Value of Cancer Treatment Options
NCCS recently submitted comments to the American Society for Clinical Oncology (ASCO) on its proposed value framework. In June, ASCO…